Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism

Jing Liu, Joanna Brzeszczynska, Kay Samuel, Jim Black, Anwar Palakkan, Richard A. Anderson, Ronald Gallagher, James A. Ross

Research output: Contribution to journalArticle

Abstract

The possibility of converting cells from blood mononuclear cells (MNC) to liver cells provides promising opportunities for the study of diseases and the assessment of new drugs. However, clinical applications have to meet GMP requirements and the methods for generating induced pluripotent cells (iPCs) have to avoid insertional mutagenesis, a possibility when using viral vehicles for the delivery of reprogramming factors. We have developed an efficient non-integration method for reprogramming fresh or frozen blood MNC, maintained in an optimised cytokine cocktail, to generate induced pluripotent cells. Using electroporation for the effective delivery of episomal transcription factors (Oct4, Sox2, Klf4, L-Myc, and Lin28) in a feeder-free system, without any requirement for small molecules, we achieved a reprogramming efficiency of up to 0.033% (65 colonies from 2×105 seeded MNC). Applying the same cytokine cocktail and reprogramming methods to cord blood or fetal liver-derived CD34+ cells, we obtained 148 iPS colonies from 105 seeding cells (0.148%). The iPS cell lines we generated maintained typical characteristics of pluripotent cells and could be successfully differentiated into hepatocytes with drug metabolic function.
Original languageEnglish
Pages (from-to)203-213
Number of pages11
JournalExperimental Cell Research
Volume338
Issue number2
Early online date6 Aug 2015
DOIs
Publication statusPublished - 30 Nov 2015
Externally publishedYes

Fingerprint

Cell Differentiation
Hepatocytes
Blood Cells
Pharmaceutical Preparations
Cytokines
Electroporation
Insertional Mutagenesis
Liver
Fetal Blood
Transcription Factors
Cell Line

Keywords

  • Stem cell
  • Reprogramming
  • Episomal
  • Pluripotent
  • Hepatocyte

Cite this

Liu, Jing ; Brzeszczynska, Joanna ; Samuel, Kay ; Black, Jim ; Palakkan, Anwar ; Anderson, Richard A. ; Gallagher, Ronald ; Ross, James A. / Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. In: Experimental Cell Research. 2015 ; Vol. 338, No. 2. pp. 203-213.
@article{70f2577e9c2a43feb9aed0ad073b0e4e,
title = "Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism",
abstract = "The possibility of converting cells from blood mononuclear cells (MNC) to liver cells provides promising opportunities for the study of diseases and the assessment of new drugs. However, clinical applications have to meet GMP requirements and the methods for generating induced pluripotent cells (iPCs) have to avoid insertional mutagenesis, a possibility when using viral vehicles for the delivery of reprogramming factors. We have developed an efficient non-integration method for reprogramming fresh or frozen blood MNC, maintained in an optimised cytokine cocktail, to generate induced pluripotent cells. Using electroporation for the effective delivery of episomal transcription factors (Oct4, Sox2, Klf4, L-Myc, and Lin28) in a feeder-free system, without any requirement for small molecules, we achieved a reprogramming efficiency of up to 0.033{\%} (65 colonies from 2×105 seeded MNC). Applying the same cytokine cocktail and reprogramming methods to cord blood or fetal liver-derived CD34+ cells, we obtained 148 iPS colonies from 105 seeding cells (0.148{\%}). The iPS cell lines we generated maintained typical characteristics of pluripotent cells and could be successfully differentiated into hepatocytes with drug metabolic function.",
keywords = "Stem cell, Reprogramming, Episomal, Pluripotent, Hepatocyte",
author = "Jing Liu and Joanna Brzeszczynska and Kay Samuel and Jim Black and Anwar Palakkan and Anderson, {Richard A.} and Ronald Gallagher and Ross, {James A.}",
year = "2015",
month = "11",
day = "30",
doi = "10.1016/j.yexcr.2015.08.004",
language = "English",
volume = "338",
pages = "203--213",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Elsevier B.V.",
number = "2",

}

Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. / Liu, Jing; Brzeszczynska, Joanna; Samuel, Kay; Black, Jim; Palakkan, Anwar; Anderson, Richard A.; Gallagher, Ronald; Ross, James A.

In: Experimental Cell Research, Vol. 338, No. 2, 30.11.2015, p. 203-213.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism

AU - Liu, Jing

AU - Brzeszczynska, Joanna

AU - Samuel, Kay

AU - Black, Jim

AU - Palakkan, Anwar

AU - Anderson, Richard A.

AU - Gallagher, Ronald

AU - Ross, James A.

PY - 2015/11/30

Y1 - 2015/11/30

N2 - The possibility of converting cells from blood mononuclear cells (MNC) to liver cells provides promising opportunities for the study of diseases and the assessment of new drugs. However, clinical applications have to meet GMP requirements and the methods for generating induced pluripotent cells (iPCs) have to avoid insertional mutagenesis, a possibility when using viral vehicles for the delivery of reprogramming factors. We have developed an efficient non-integration method for reprogramming fresh or frozen blood MNC, maintained in an optimised cytokine cocktail, to generate induced pluripotent cells. Using electroporation for the effective delivery of episomal transcription factors (Oct4, Sox2, Klf4, L-Myc, and Lin28) in a feeder-free system, without any requirement for small molecules, we achieved a reprogramming efficiency of up to 0.033% (65 colonies from 2×105 seeded MNC). Applying the same cytokine cocktail and reprogramming methods to cord blood or fetal liver-derived CD34+ cells, we obtained 148 iPS colonies from 105 seeding cells (0.148%). The iPS cell lines we generated maintained typical characteristics of pluripotent cells and could be successfully differentiated into hepatocytes with drug metabolic function.

AB - The possibility of converting cells from blood mononuclear cells (MNC) to liver cells provides promising opportunities for the study of diseases and the assessment of new drugs. However, clinical applications have to meet GMP requirements and the methods for generating induced pluripotent cells (iPCs) have to avoid insertional mutagenesis, a possibility when using viral vehicles for the delivery of reprogramming factors. We have developed an efficient non-integration method for reprogramming fresh or frozen blood MNC, maintained in an optimised cytokine cocktail, to generate induced pluripotent cells. Using electroporation for the effective delivery of episomal transcription factors (Oct4, Sox2, Klf4, L-Myc, and Lin28) in a feeder-free system, without any requirement for small molecules, we achieved a reprogramming efficiency of up to 0.033% (65 colonies from 2×105 seeded MNC). Applying the same cytokine cocktail and reprogramming methods to cord blood or fetal liver-derived CD34+ cells, we obtained 148 iPS colonies from 105 seeding cells (0.148%). The iPS cell lines we generated maintained typical characteristics of pluripotent cells and could be successfully differentiated into hepatocytes with drug metabolic function.

KW - Stem cell

KW - Reprogramming

KW - Episomal

KW - Pluripotent

KW - Hepatocyte

U2 - 10.1016/j.yexcr.2015.08.004

DO - 10.1016/j.yexcr.2015.08.004

M3 - Article

VL - 338

SP - 203

EP - 213

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -